NantHealth (NH) & ZIX (ZIXI) Critical Survey
ZIX (NASDAQ:ZIXI) and NantHealth (NASDAQ:NH) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.
Volatility and Risk
ZIX has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, NantHealth has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.
71.3% of ZIX shares are owned by institutional investors. Comparatively, 5.2% of NantHealth shares are owned by institutional investors. 3.7% of ZIX shares are owned by company insiders. Comparatively, 64.9% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This is a summary of current ratings and target prices for ZIX and NantHealth, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
ZIX currently has a consensus target price of $7.17, suggesting a potential upside of 16.91%. NantHealth has a consensus target price of $4.75, suggesting a potential upside of 535.20%. Given NantHealth’s higher probable upside, analysts plainly believe NantHealth is more favorable than ZIX.
Earnings and Valuation
This table compares ZIX and NantHealth’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|ZIX||$65.66 million||5.06||-$8.05 million||$0.08||76.63|
|NantHealth||$86.68 million||0.94||-$175.21 million||($1.12)||-0.67|
ZIX has higher earnings, but lower revenue than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than ZIX, indicating that it is currently the more affordable of the two stocks.
This table compares ZIX and NantHealth’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
ZIX beats NantHealth on 8 of the 12 factors compared between the two stocks.
Zix Corporation provides email encryption, threat protection, archiving, bring-your-own-device security, and data loss prevention solutions for the healthcare, financial services, insurance, and government sectors primarily in the United States. The company offers Zix Email Encryption that allows an enterprise to use policy-driven rules to determine email messages that should be sent securely to comply with regulations or company-defined policies. It a0lso provides ZixDirectory, an email encryption community to share identities; Best Method of Delivery, a protocol that automatically determines means of delivery based on the sender's and recipient's communications environment and preferences; and ZixEncrypt, which automatically encrypts and decrypts messages with sensitive content. In addition, the company offers ZixProtect that defends organizations from zero-day malware, ransomware, phishing, CEO fraud, W-2 phishing attacks, spam, and viruses in email; and ZixArchive, a cloud-based email retention solution that enables user retrieval, compliance, and e-discovery. Further, it provides ZixOne, a mobile email app, which offers access to corporate email while never allowing that data to be persistently stored on the device where it is vulnerable to loss or theft. Zix Corporation offers its services through a direct sales force; and a network of resellers and other distribution partners. It has strategic partnership with Digital Guardian to deliver email encryption with enterprise data loss prevention. The company was formerly known as ZixIt Corporation and changed its name to Zix Corporation in 2002. Zix Corporation was founded in 1983 and is headquartered in Dallas, Texas.
NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Receive News & Ratings for ZIX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIX and related companies with MarketBeat.com's FREE daily email newsletter.